S&P 500   4,440.65 (-0.19%)
DOW   34,706.08 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.65 (-0.19%)
DOW   34,706.08 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.65 (-0.19%)
DOW   34,706.08 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
S&P 500   4,440.65 (-0.19%)
DOW   34,706.08 (-0.17%)
QQQ   371.34 (-0.44%)
AAPL   146.02 (-0.55%)
MSFT   297.71 (-0.62%)
FB   347.67 (+0.49%)
GOOGL   2,831.00 (+0.24%)
TSLA   762.47 (+1.17%)
AMZN   3,397.67 (-0.54%)
NVDA   218.92 (-2.62%)
BABA   145.67 (-3.65%)
NIO   35.43 (-1.61%)
CGC   13.95 (-4.19%)
GE   104.17 (+1.18%)
MU   74.33 (+0.39%)
AMD   105.03 (-1.06%)
T   27.25 (+0.22%)
F   13.94 (+1.68%)
ACB   6.00 (-2.44%)
DIS   175.40 (-0.48%)
PFE   44.06 (-0.29%)
BA   221.36 (+0.12%)
BAC   42.23 (+1.30%)
CNSX:SNN

Smith & Nephew Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume44,398 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.


Smith & Nephew logo

About Smith & Nephew

Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.

Headlines

4 Top Healthcare Stocks to Buy in September
4 Top Healthcare Stocks to Buy in September
September 14, 2021 |  stocknews.com
Smith & Nephew Enters Oversold Territory (SNN)
Smith & Nephew Enters Oversold Territory (SNN)
September 9, 2021 |  nasdaq.com
Smith & Nephew plc: Smith+Nephew introduces pioneering new technologies for its JOURNEY II total knee arthroplasty portfolio
Smith & Nephew plc: Smith+Nephew introduces pioneering new technologies for its JOURNEY II total knee arthroplasty portfolio
September 1, 2021 |  finanznachrichten.de
Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio
Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio
September 1, 2021 |  finance.yahoo.com
Smith & Nephew plc: Smith+Nephews OXINIUM Technology recognized as the best performing bearing with lowest risk of revision in total hip arthroplasty
Smith & Nephew plc: Smith+Nephew's OXINIUM Technology recognized as the best performing bearing with lowest risk of revision in total hip arthroplasty
August 31, 2021 |  finanznachrichten.de
Will a Powerful Acquisition Make This Early 2021 IPO a Buy?
Will a Powerful Acquisition Make This Early 2021 IPO a Buy?
August 17, 2021 |  finance.yahoo.com
Questor: it’s not immune from inflation but Smith & Nephew is a quality business. Keep buying
Questor: it’s not immune from inflation but Smith & Nephew is a quality business. Keep buying
August 10, 2021 |  uk.finance.yahoo.com
What You Need To Know About Smith & Nephew plcs (LON:SN.) Investor Composition
What You Need To Know About Smith & Nephew plc's (LON:SN.) Investor Composition
August 9, 2021 |  finance.yahoo.com
Smith & Nephew plc 2021 Q2 - Results - Earnings Call Presentation
Smith & Nephew plc 2021 Q2 - Results - Earnings Call Presentation
July 29, 2021 |  seekingalpha.com
Relative Strength Alert For Smith & Nephew
Relative Strength Alert For Smith & Nephew
July 19, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Smith & Nephew (CNSX:SNN) Frequently Asked Questions

What stocks does MarketBeat like better than Smith & Nephew?

Wall Street analysts have given Smith & Nephew a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Smith & Nephew wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:
  • Dr. Anthony F. Holler, Co-founder, CEO & Chairman (Age 69, Pay $340.63k)
  • Dr. Mark Hamish Kimmins, Pres of NHS (Age 54, Pay $4.68M)
  • Mr. David Weinmann, Global Controller & Interim CFO
  • Rob Knowles, VP of Corp. Devel.
  • Mr. Jose Calderon, Head of Grower

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Canopy Growth (WEED), Energous (WATT), Cronos Group (CRON), Aurora Cannabis (ACB), (CGC), Aurora Cannabis (ACB), CanniMed Therapeutics (CMED), CannTrust (CTST), CannaRoyalty (CNNRF) and Innovative Industrial Properties (IIPR).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the CNSX under the ticker symbol "SNN."

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Smith & Nephew have?

Smith & Nephew employs 18,581 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.sunniva.com.

Where are Smith & Nephew's headquarters?

Smith & Nephew is headquartered at Suite 400, 355 – 4th Avenue S.W. Calgary, AB T2P 0J1.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is Suite 400, 355 – 4th Avenue S.W. Calgary, AB T2P 0J1. The company can be reached via phone at 1-866-SUNNIVA.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.